You are here
Our Advances in CF
Our cystic fibrosis program began as a small research project in 1998. Today, Vertex has the most CF compounds in clinical development in the industry, and is focused on developing medicines for all people with CF. Learn about our leading role in creating medicines that address the underlying cause of CF.